RT Journal Article
SR Electronic
T1 Multiscale integration of human and single-cell variations reveals unadjuvanted vaccine high responders are naturally adjuvanted
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.20.23287474
DO 10.1101/2023.03.20.23287474
A1 Mulè, Matthew P.
A1 Martins, Andrew J.
A1 Cheung, Foo
A1 Farmer, Rohit
A1 Sellers, Brian
A1 Quiel, Juan A.
A1 Jain, Arjun
A1 Kotliarov, Yuri
A1 Bansal, Neha
A1 Chen, Jinguo
A1 Schwartzberg, Pamela L.
A1 Tsang, John S.
YR 2023
UL http://medrxiv.org/content/early/2023/03/20/2023.03.20.23287474.abstract
AB Advances in multimodal single cell analysis can empower high-resolution dissection of human vaccination responses. The resulting data capture multiple layers of biological variations, including molecular and cellular states, vaccine formulations, inter- and intra-subject differences, and responses unfolding over time. Transforming such data into biological insight remains a major challenge. Here we present a systematic framework applied to multimodal single cell data obtained before and after influenza vaccination without adjuvants or pandemic H5N1 vaccination with the AS03 adjuvant. Our approach pinpoints responses shared across or unique to specific cell types and identifies adjuvant specific signatures, including pro-survival transcriptional states in B lymphocytes that emerged one day after vaccination. We also reveal that high antibody responders to the unadjuvanted vaccine have a distinct baseline involving a rewired network of cell type specific transcriptional states. Remarkably, the status of certain innate immune cells in this network in high responders of the unadjuvanted vaccine appear “naturally adjuvanted”: they resemble phenotypes induced early in the same cells only by vaccination with AS03. Furthermore, these cell subsets have elevated frequency in the blood at baseline and increased cell-intrinsic phospho-signaling responses after LPS stimulation ex vivo in high compared to low responders. Our findings identify how variation in the status of multiple immune cell types at baseline may drive robust differences in innate and adaptive responses to vaccination and thus open new avenues for vaccine development and immune response engineering in humans.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was funded by the Intramural Program of NIAID and the Institutes and Centers supporting the Trans-NIH Center for Human Immunology.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval provided by NIH Office of Human Subjects Research Protections, Office of IRB Operations.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData produced in the present study are available at: https://github.com/niaid/fsc and upon reasonable request to the authors. Select human subject data may not be available for some subjects because study participants did not provide consent for data deposition. https://github.com/niaid/fsc